Benjamin Kably

665 total citations
14 papers, 155 citations indexed

About

Benjamin Kably is a scholar working on Epidemiology, Surgery and Pharmacology. According to data from OpenAlex, Benjamin Kably has authored 14 papers receiving a total of 155 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Surgery and 4 papers in Pharmacology. Recurrent topics in Benjamin Kably's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Medication Adherence and Compliance (3 papers) and Blood Pressure and Hypertension Studies (3 papers). Benjamin Kably is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Medication Adherence and Compliance (3 papers) and Blood Pressure and Hypertension Studies (3 papers). Benjamin Kably collaborates with scholars based in France, Switzerland and Netherlands. Benjamin Kably's co-authors include Eliane M. Billaud, Manon Launay, Éric Dannaoui, Sandrine Lefeuvre, Michel Azizi, Pierre Boutouyrie, Lucien Lécuyer, Prashanth Patel, Maciej Tomaszewski and L. Beaumont and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Journal of Medical Internet Research and American Journal of Transplantation.

In The Last Decade

Benjamin Kably

13 papers receiving 154 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Kably France 7 50 48 34 26 20 14 155
Małgorzata Mikaszewska-Sokolewicz Poland 8 37 0.7× 147 3.1× 17 0.5× 4 0.2× 2 0.1× 24 274
Maria Amicone Italy 6 14 0.3× 24 0.5× 13 0.4× 2 0.1× 3 0.1× 20 175
Devin Harris Canada 7 37 0.7× 21 0.4× 33 1.0× 3 0.1× 20 170
Luís Bento Portugal 10 26 0.5× 87 1.8× 20 0.6× 7 0.3× 45 238
José María Fernández Rodríguez Spain 6 40 0.8× 43 0.9× 12 0.4× 2 0.1× 20 134
Robert O. Fullinfaw Australia 8 50 1.0× 17 0.4× 3 0.1× 2 0.1× 23 1.1× 14 258
Alice Raillard France 8 36 0.7× 72 1.5× 22 0.6× 5 0.2× 11 182
Eva Grolimund Switzerland 6 16 0.3× 154 3.2× 41 1.2× 7 0.3× 7 233
Andrea C. Hall United States 4 22 0.4× 38 0.8× 23 0.7× 6 0.2× 7 88
Rubén Herrán‐Monge Spain 7 15 0.3× 135 2.8× 12 0.4× 5 0.2× 11 235

Countries citing papers authored by Benjamin Kably

Since Specialization
Citations

This map shows the geographic impact of Benjamin Kably's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Kably with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Kably more than expected).

Fields of papers citing papers by Benjamin Kably

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Kably. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Kably. The network helps show where Benjamin Kably may publish in the future.

Co-authorship network of co-authors of Benjamin Kably

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Kably. A scholar is included among the top collaborators of Benjamin Kably based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Kably. Benjamin Kably is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kably, Benjamin, Mathilde Briard, Claire Francoz, et al.. (2025). Population pharmacokinetics of aciclovir and its major metabolite 9-carboxymethoxymethylguanine and safety profile of valaciclovir in early liver transplant recipients. Journal of Antimicrobial Chemotherapy. 80(5). 1302–1308. 1 indexed citations
2.
Gras, Emmanuelle, Benjamin Kably, Agnés Lillo‐Le Louët, et al.. (2023). Prospective assessment of the frequency of and risk factors for bleeding events in patients treated with cefazolin. Infection. 52(2). 557–566.
3.
Korb‐Savoldelli, Virginie, G Perrin, Jean Pastré, et al.. (2023). Psychometric Properties of a Machine Learning–Based Patient-Reported Outcome Measure on Medication Adherence: Single-Center, Cross-Sectional, Observational Study. Journal of Medical Internet Research. 25. e42384–e42384. 6 indexed citations
4.
Magréault, Sophie, Younes Kerroumi, Dominique Salmon, et al.. (2023). What clindamycin dose should be administered by continuous infusion during combination therapy with rifampicin? A prospective population pharmacokinetics study. Journal of Antimicrobial Chemotherapy. 78(12). 2943–2949. 1 indexed citations
5.
Correia, Patricia, et al.. (2022). Ceftazidime dosing in obese patients: is it time for more?. Expert Opinion on Drug Metabolism & Toxicology. 18(4). 277–284. 2 indexed citations
6.
Kably, Benjamin, et al.. (2022). Antifungal Drugs TDM: Trends and Update.. PubMed. 44(1). 166–197. 20 indexed citations
7.
Kably, Benjamin, et al.. (2022). Dried Urine Spot Analysis for assessing cardiovascular drugs exposure applicable in spaceflight conditions. Journal of Chromatography B. 1219. 123539–123539. 7 indexed citations
8.
Magréault, Sophie, Younes Kerroumi, Dominique Salmon, et al.. (2022). Population Pharmacokinetics of Orally Administered Clindamycin to Treat Prosthetic Joint Infections: A Prospective Study. Antibiotics. 11(11). 1462–1462. 2 indexed citations
9.
Lawson, Alexander J., Michel Azizi, Michel Burnier, et al.. (2021). Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing. UCL Discovery (University College London). 35 indexed citations
10.
Kably, Benjamin, et al.. (2021). Antifungal Drugs TDM: Trends and Update. Therapeutic Drug Monitoring. 44(1). 166–197. 48 indexed citations
11.
Kably, Benjamin, David Fouassier, Aurélien Lorthioir, et al.. (2021). LONG-TERM ADHERENCE TO ANTIHYPERTENSIVE TREATMENT BY URINARY/PLASMA DETECTION IN PATIENTS WITH RESISTANT HYPERTENSION IN THE RENAL DENERVATION FOR HYPERTENSION (DENERHTN) TRIAL. Journal of Hypertension. 39(Supplement 1). e42–e42. 1 indexed citations
12.
Kably, Benjamin, Eliane M. Billaud, Pierre Boutouyrie, & Michel Azizi. (2020). Is there any Hope for Monitoring Adherence in an Efficient and Feasible Way for Resistant Hypertension Diagnosis and Follow-Up?. Current Hypertension Reports. 22(11). 96–96. 7 indexed citations
13.
Launay, Manon, Joëlle Guitard, Richard Dorent, et al.. (2019). Belatacept-based immunosuppression: A calcineurin inhibitor-sparing regimen in heart transplant recipients. American Journal of Transplantation. 20(2). 553–563. 22 indexed citations
14.
Kably, Benjamin, et al.. (2017). Impact de l’implantation d’armoires sécurisées dédiés aux dispositifs médicaux dans un service de chirurgie cardiaque. Annales Pharmaceutiques Françaises. 76(1). 64–70. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026